top of page
Search

Why methane-cutting additives in cattle require more than promising science

Cows on green grass field

Methane-reducing feed additives are a technology with the potential to lower greenhouse gas emissions from cattle farming. These additives work by reducing enteric methane from rumen fermentation. To do so, they alter the processes that generate methane or directly interfere with the biological pathways responsible for its formation in cattle.


In recent years, a number of such additives have been developed, most notably 3-nitrooxypropanol (3-NOP; marketed as Bovaer) and red seaweed-derived compounds containing bromoform. In controlled feeding trials, these additives have demonstrated potential to significantly reduce enteric methane emissions, with some studies reporting reductions of more than 30% for 3-NOP and even higher reductions for red seaweed-derived compounds.


However, trial efficacy is only the starting point for achieving meaningful emission reductions. Whether methane reductions observed under controlled trial conditions translate into emissions mitigation on commercial farms depends on a broad set of factors, including cost, animal health and productivity outcomes, and the ability to verify emissions reductions at scale. Commercial adoption depends not only on whether an additive can lower methane in an experimental setting, but on whether it can be implemented safely, practically, and profitably in commercial settings.


Denmark's recent experience with 3-NOP exemplifies this challenge. Strong trial evidence, regulatory approval, and a supportive policy environment mandated the rapid rollout of 3-NOP. Yet this rollout also exposed the difficulties of moving from scientific validation to commercial application, as dairy farmers raised concerns about animal health and production performance. Denmark’s experience underscores a broader lesson for methane-reducing feed additives and other emerging feed technologies: sustained farmer adoption requires much more than promising experimental results. 


Denmark’s mandate as a real-world test


Starting in January 2025, Denmark required conventional dairy farms with more than 50 cows to feed a methane-reducing additive for at least 80 days a year or shift to a high-fat diet as part of efforts to reduce livestock greenhouse gas emissions. 3-NOP, approved in the EU since 2022 and authorised in approximately 70 countries, has become the primary product used to meet the requirement and is among the most extensively studied methane inhibitors currently available.


Following implementation, farmers began reporting concerns related to animal health and production performance. The European Commission subsequently asked EFSA to reopen its target-species safety assessment after roughly a quarter of the approximately 1,600 Danish dairy farms that adopted 3-NOP reported clinical signs consistent with digestive and metabolic disorders, alongside lower feed intake and milk yields. The scale and speed of the reports also contributed to Norway’s decision to pause its own trials.


The evidence that has emerged since has complicated the story without resolving it. A retrospective analysis of 73 Danish dairy herds conducted by Aarhus University did not demonstrate a significant association between 3-NOP administration and the reported dairy herd health issues. Some farmers remain unconvinced, and EFSA has postponed the publication of its updated assessment due to the volume of data submitted for review.


At present, no evidence has established a causal relationship between 3-NOP and the reported health and performance concerns. However, the lack of evidence of causation hasn’t been enough to restore farmers' confidence. Denmark’s experience demonstrates that while trial evidence and regulatory approval were necessary for deployment, they weren’t sufficient to secure sustained adoption and confidence among farmers and the broader dairy industry. Perceived risk, trust, social acceptance, and clear economic incentives are important drivers of technology uptake, regardless of the strength of the underlying safety evidence. 


Red seaweed faces a similar challenge


Red seaweed-derived additives illustrate a different gap between research and real-world implementation. Compounds derived from Asparagopsis seaweed, whose methane-reducing effects stem from bromoform, have shown substantial reductions in enteric methane when delivered as pelleted feed. However, a separate field trial that delivered the same compound through free-choice mineral supplementation did not reproduce comparable results, likely due to low intake, inconsistent dosing, and possible degradation during storage and delivery. 


The broader climate benefits of red seaweed-derived additives also depend on conditions beyond methane reduction alone. A life-cycle assessment found that seaweed-derived additives often deliver only modest net greenhouse gas benefits in real-world scenarios once processing, transport, and sourcing are accounted for. Despite their "natural" origin, bromoform-containing seaweed additives also raise questions around product safety, residues, and animal health due to the compound’s toxicological profile and remaining uncertainties around long-term exposure. 


From efficacy to adoption 


Together, these case studies illustrate that demonstrating efficacy in trials is only the first step toward achieving sustained adoption and meaningful emissions reductions on commercial farms. Several methane-reducing feed additives have demonstrated strong potential and are likely to remain an important part of the livestock sector’s near-term mitigation toolkit. Yet moving from controlled trials to commercial practice introduces new challenges.


Methane-reducing additives are fed to living animals, managed by farmers, and integrated into commercial farms operating under tight margins. Despite substantial research and investment, the real test for these additives will be whether they can deliver verifiable environmental outcomes at scale under working farm conditions while maintaining animal performance, economic viability, and farmer trust. Scientific evidence and regulatory approval can demonstrate technical potential, but translating that potential into sustained adoption depends on how technologies perform in practice and how well they fit within the realities of farm management.


Ultimately, whether methane-reducing feed additives move from promising innovations to effective climate mitigation tools will depend on more than just technical performance. Measurement reliability, implementation experience, economic feasibility, and farmer confidence will all influence their trajectory. Achieving meaningful emissions reductions at scale will require these factors to align, with trust, performance, and practicality reinforcing one another over time.


 
 
The Centre for Feed Innovation logo 3

CFI is a not-for-profit company limited by guarantee, registered in England and Wales (Company No. 16523680).  CFI also operates through a fiscal sponsorship with Players Philanthropy Fund (Federal Tax ID: 27-6601178, ppf.org/pp), a Maryland charitable trust with federal tax-exempt status as a public charity under Section 501(c)(3) of the Internal Revenue Code.

  • X
  • LinkedIn
bottom of page